Literature DB >> 19221704

[Multidrug resistance-associated proteins in malignant melanoma. Molecular markers for therapy].

A F Wendel1, C Skazik, H F Merk, J M Baron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19221704     DOI： 10.1007/s00105-008-1690-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  6 in total

Review 1.  Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.

Authors:  Roger G Deeley; Christopher Westlake; Susan P C Cole
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

2.  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes.

Authors:  J M Baron; D Höller; R Schiffer; S Frankenberg; M Neis; H F Merk; F K Jugert
Journal:  J Invest Dermatol       Date:  2001-04       Impact factor: 8.551

3.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.

Authors:  Glen Reid; Peter Wielinga; Noam Zelcer; Ingrid van der Heijden; Annemieke Kuil; Marcel de Haas; Jan Wijnholds; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

4.  Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin.

Authors:  Bernd Liedert; Verena Materna; Dirk Schadendorf; Jürgen Thomale; Hermann Lage
Journal:  J Invest Dermatol       Date:  2003-07       Impact factor: 8.551

5.  Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.

Authors:  Susanne Heimerl; Anja K Bosserhoff; Thomas Langmann; Josef Ecker; Gerd Schmitz
Journal:  Melanoma Res       Date:  2007-10       Impact factor: 3.599

6.  Membrane transport proteins associated with drug resistance expressed in human melanoma.

Authors:  D Schadendorf; A Makki; C Stahr; A van Dyck; R Wanner; G L Scheffer; M J Flens; R Scheper; B M Henz
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.